G&E Herbal Biotechnology Co., Ltd.(TW:4911)
NT$25.00-0.30 (-1.19%)
TW:4911
G&E Herbal Biotechnology Co., Ltd. Revenue
NT$25.00
At close:-0.30 (-1.19%)
G&E Herbal Biotechnology Co., Ltd. (4911) Revenue
G&E Herbal Biotechnology Co., Ltd. Revenue
G&E Herbal Biotechnology Co., Ltd. had a revenue of 34.44M in the quarter ending Jun 30, 2026, with 6.91%. This bring the company's revenue in the last twelve months to 215.61M, Decreased 17.46%. In the fiscal year ending Dec 31, 2025, G&E Herbal Biotechnology Co., Ltd. had annual revenue of 309.13M with 24.13% growth.
- Revenue (ttm)
- 215.61M
- Revenue Growth
- -26.73%
- P/S Ratio
- 5.63
- Revenue/Employee
- TWD 8,135,053
- Employees
- 38
- Market Cap
- TWD 1.74B
Revenue Chart
G&E Herbal Biotechnology Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 309.13M | 60.10M | 24.13% |
| Dec 31, 2024 | 249.03M | 67.59M | 37.25% |
| Dec 31, 2023 | 181.44M | 116.84M | 180.84% |
| Dec 31, 2022 | 64.61M | 40.04M | 162.94% |
| Dec 31, 2021 | 24.57M | -3.66M | -12.96% |
| Dec 31, 2020 | 28.23M | 10.68M | 60.82% |
| Dec 31, 2019 | 17.55M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.